AngioSoma, Inc. Acquires Patented Nutraceutical for Muscle Mass Development

MONTGOMERY, Texas — (BUSINESS WIRE, November 17, 2016 09:45 AM Eastern Standard Time) — AngioSoma, Inc. (OTCQB: SOAN) announces that its new subsidiary Soma Nutraceuticals, Inc. is the recipient of intellectual property conveyed by its Chairman Emeritus Dr. David Summers, including a nutraceutical product using either natural or synthetic nicotine in a patented method for Read more about AngioSoma, Inc. Acquires Patented Nutraceutical for Muscle Mass Development[…]